{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:12:28Z","timestamp":1781421148364,"version":"3.54.1"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,20]]},"DOI":"10.18632\/oncotarget.10748","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T08:11:15Z","timestamp":1469088675000},"page":"61152-61165","source":"Crossref","is-referenced-by-count":7,"title":["Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2"],"prefix":"10.18632","volume":"7","author":[{"given":"Alexander A.","family":"Goldberg","sequence":"first","affiliation":[{"name":"Meakins-Christie Laboratories, Translational Research in Respiratory Diseases Program, Montreal, Quebec, Canada"},{"name":"Department of Critical Care Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Bo","family":"Joung","sequence":"additional","affiliation":[{"name":"Meakins-Christie Laboratories, Translational Research in Respiratory Diseases Program, Montreal, Quebec, Canada"},{"name":"Department of Critical Care Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Mansuri","sequence":"additional","affiliation":[{"name":"Meakins-Christie Laboratories, Translational Research in Respiratory Diseases Program, Montreal, Quebec, Canada"},{"name":"Department of Critical Care Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Kang","sequence":"additional","affiliation":[{"name":"Meakins-Christie Laboratories, Translational Research in Respiratory Diseases Program, Montreal, Quebec, Canada"},{"name":"Department of Critical Care Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Echavarria","sequence":"additional","affiliation":[{"name":"Meakins-Christie Laboratories, Translational Research in Respiratory Diseases Program, Montreal, Quebec, Canada"},{"name":"Department of Critical Care Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Nikolajev","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane J.","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane A.","family":"Laporte","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Schwertani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Montreal General Hospital, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Kristof","sequence":"additional","affiliation":[{"name":"Meakins-Christie Laboratories, Translational Research in Respiratory Diseases Program, Montreal, Quebec, Canada"},{"name":"Department of Critical Care Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Henske","year":"2006","journal-title":"N. Eng. J. Med"},{"key":"2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0733-8619(03)00004-5","article-title":"Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases","volume":"21","author":"Kandt","year":"2003","journal-title":"Neurologic clinics"},{"key":"3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/lrb.2009.0018","article-title":"Lymphangioleiomyomatosis: a disease involving the lymphatic system","volume":"8","author":"Sato","year":"2010","journal-title":"Lymphat. Res. Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis - a wolf in sheep's clothing","volume":"122","author":"McCormack","year":"2012","journal-title":"J. Clin. Invest"},{"key":"5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Manning","year":"2009","journal-title":"Biochem. Soc. Trans"},{"key":"6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/lrb.2009.0019","article-title":"mTOR Signaling in Lymphangioleiomyomatosis","volume":"8","author":"Kristof","year":"2010","journal-title":"Lymphat. Res. Biol"},{"key":"7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Crone","year":"2006","journal-title":"Ann Neurol"},{"key":"8","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","author":"Sahmoud","year":"2013","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis","volume":"364","author":"Goldberg","year":"2011","journal-title":"N. Eng. J. Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1517\/14740338.2013.752814","article-title":"Adverse events associated with mTOR inhibitors","volume":"12","author":"Legendre","year":"2013","journal-title":"Expert opinion on drug safety"},{"key":"11","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Cantley","year":"2005","journal-title":"Genes Dev"},{"key":"12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4161\/cc.8.4.7659","article-title":"Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance and cancer therapy","volume":"8","author":"Blenis","year":"2009","journal-title":"Cell Cycle"},{"key":"13","first-page":"4","article-title":"mTOR-dependent cell survival mechanisms","author":"Guertin","year":"2012","journal-title":"Cold Spring Harbor perspectives in biology"},{"key":"14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.peptides.2010.04.017","article-title":"Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis","volume":"31","author":"Giaid","year":"2010","journal-title":"Peptides"},{"key":"15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/14081","article-title":"Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction","volume":"1","author":"Civelli","year":"1999","journal-title":"Nat Cell Biol"},{"key":"16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/45809","article-title":"Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14","volume":"401","author":"Holmes","year":"1999","journal-title":"Nature"},{"key":"17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.peptides.2007.10.027","article-title":"Biological properties and functional determinants of the urotensin II receptor","volume":"29","author":"Leduc","year":"2008","journal-title":"Peptides"},{"key":"18","first-page":"1102","article-title":"Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ","volume":"88","author":"Loirand","year":"2001","journal-title":"Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.bjp.0705254","article-title":"Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice","volume":"139","author":"Douglas","year":"2003","journal-title":"Br. J. Pharmacol"},{"key":"20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1210\/jc.2008-1131","article-title":"Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism","volume":"94","author":"Rossi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1196\/annals.1353.032","article-title":"The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues","volume":"1073","author":"Liu","year":"2006","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.peptides.2004.03.028","article-title":"Role of urotensin II in peripheral tissue as an autocrine\/paracrine growth factor","volume":"25","author":"Hirata","year":"2004","journal-title":"Peptides"},{"key":"23","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/en.2003-0029","article-title":"Urotensin II is an autocrine\/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1","volume":"144","author":"Hirata","year":"2003","journal-title":"Endocrinology"},{"key":"24","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/sj.onc.1205962","article-title":"Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration","volume":"21","author":"Henske","year":"2002","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"crossref","first-page":"e3558","DOI":"10.1371\/journal.pone.0003558","article-title":"Anti-EGFR antibody efficiently and specifically inhibits human TSC2\u2212\/\u2212 smooth muscle cell proliferation. Possible treatment options for TSC and LAM","volume":"3","author":"Gorio","year":"2008","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4049\/jimmunol.179.2.901","article-title":"Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes","volume":"179","author":"Pacaud","year":"2007","journal-title":"J Immunol"},{"key":"27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrm1549","article-title":"Focal adhesion kinase: in command and control of cell motility","volume":"6","author":"Schlaepfer","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2353\/ajpath.2010.090233","article-title":"Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition","volume":"177","author":"Yeung","year":"2010","journal-title":"Am. J. Pathol"},{"key":"29","first-page":"2169","article-title":"Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity","volume":"24","author":"Koutsilieris","year":"2004","journal-title":"Anticancer Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0960-9822(03)00544-X","article-title":"A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src","volume":"13","author":"Frame","year":"2003","journal-title":"Curr. Biol"},{"key":"31","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Henske","year":"2004","journal-title":"Am. J. Physiolo. Lung Cell Mol. Physiol"},{"key":"32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20131080","article-title":"Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells","volume":"211","author":"Morrison","year":"2014","journal-title":"J. Exp. Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1164\/rccm.201205-0848OE","article-title":"Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm","volume":"186","author":"Moss","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"34","first-page":"69","article-title":"The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis","volume":"2","author":"Stanford","year":"2014","journal-title":"Frontiers in cell and developmental biology"},{"key":"35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor","volume":"167","author":"Gorio","year":"2005","journal-title":"The Amer. J. Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"R1156","DOI":"10.1152\/ajpregu.00706.2009","article-title":"Role of urotensin II in health and disease","volume":"298","author":"Giaid","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Phsyiol"},{"key":"37","first-page":"211","article-title":"Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex","volume":"7","author":"Franz","year":"2013","journal-title":"Biologics: targets & therapy"},{"key":"38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1083\/jcb.200405130","article-title":"TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase","volume":"167","author":"Krymskaya","year":"2004","journal-title":"J Cell Biol"},{"key":"39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0196-9781(01)00441-7","article-title":"Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells","volume":"22","author":"Shibahara","year":"2001","journal-title":"Peptides"},{"key":"40","doi-asserted-by":"crossref","first-page":"23114","DOI":"10.1074\/jbc.M401912200","article-title":"Estrogen-induced smooth muscle cell growth is regulated by tuberin and associated with altered activation of platelet-derived growth factor receptor-beta and ERK-1\/2","volume":"279","author":"Noonan","year":"2004","journal-title":"J. Biol. Chem"},{"key":"41","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Henske","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Schlaepfer","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1242\/jcs.01481","article-title":"MAP kinases and cell migration","volume":"117","author":"Schaller","year":"2004","journal-title":"J Cell Sci"},{"key":"44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0024-3205(02)02346-9","article-title":"Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling","volume":"72","author":"Nakashima","year":"2003","journal-title":"Life sciences"},{"key":"45","article-title":"Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis","author":"Blenis","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"46","article-title":"Mammalian target of rapamycin complex 1 (mTORC1) enhances bortezomib-induced death in tuberous sclerosis complex (TSC)-null cells by a c-MYC-dependent induction of the unfolded protein response","author":"Quilliam","year":"2013","journal-title":"J. Biol. Chem"},{"key":"47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0196-9781(03)00039-1","article-title":"Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II","volume":"24","author":"Shibahara","year":"2003","journal-title":"Peptides"},{"key":"48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/bja\/aem088","article-title":"Urotensin II: from osmoregulation in fish to cardiovascular regulation in man","volume":"98","author":"Lambert","year":"2007","journal-title":"Br. J. Anaesth"},{"key":"49","first-page":"1568","article-title":"Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines","volume":"146","author":"Walker","year":"1995","journal-title":"Amer. J. Pathol"},{"key":"50","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1074\/jbc.M111.246785","article-title":"Regulation of Karyopherin-alpha1 and nuclear import by mTOR","volume":"287","author":"Kristof","year":"2012","journal-title":"J. Biol. Chem"},{"key":"51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T10:58:38Z","timestamp":1589281118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":51,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,9,20]]}},"alternative-id":["10748","27458154"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10748","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}